What's next for pharma whistleblowers
Friday, October 23rd, 2009
By: Kerry Grens
kgrens@whyy.org
The biggest lawsuit settlements against pharmaceutical companies happened this year…and they happened in Philadelphia. Some of the lawyers involved in those cases met at Drexel University recently to discuss the future of lawsuits like these.
Listen:
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Stephen Sheller represented some of the whistleblowers that brought on a massive penalty against drug company Eli Lilly. The company was accused of marketing an anti-psychotic drug for conditions that the FDA didn't OK.
Sheller explains, there's a lot of money at stake when drug companies mis-market their medications.
Sheller: 2.3 billion in Pfizer, 1.415 billion in the Lilly case. That's $3.7 billion dollars this year…You're going to see more of it. And with the Obama administration, hopefully we'll see some real enforcement.
Tom Gallagher represented Eli Lilly. He says there's an expectation that the Obama administration will give greater scrutiny to drug advertising.
Gallagher: Will enforcement increase? I suspect it will. I suspect it will be signifcant attention being paid by the government on these companies. And I can assure that companies know that and are also increasing their commitment to compliance as well.
Lawyers at the event say they expect health care reform will lead to additional lawsuits against pharmceutical companies. They say that's because a bigger health care industry provides more opportunities for fraud.
Eli Lilly has made $38 billion on Zyprexa and it was way oversold and caused diabetes and in some cases sudden death.
Eli Lilly has received a huge criminal fine over their Zyprexa cash cow,add it all up comes to $4.6 billion, in Zyprexa settlements,fines,litigation.
Addictive Zyprexa was pushed by Lilly Drug Reps.
They called it the "Five at Five" (5 mg at 5 pm to keep nursing home patients subdued and sleepy) and "VIVA ZYPREXA" (Zyprexa for everybody) campaigns to off label market Eli Lilly Zyprexa as a fix for unapproved usage.
Eli Lilly is 'reaping the whirlwind' for aggressive marketing of Zyprexa that has caused suffering and deaths.
There must be millions out there harmed by this drug.
Daniel Haszard http://www.zyprexa-victims.com